GovChime
Notice ID: bf6b20798a274eb2936262d401e097a7Special Notice

Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center

Archived on November 7, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM EDT
Posted
October 8, 2026
Notice type
Special Notice
Set-aside
No Set aside used
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Place of performance
Bethesda, Maryland, 20892
Last updated
Nov 7, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
NOI-OLAO-CC-27-000121
Notice ID
bf6b20798a274eb2936262d401e097a7

Description

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Fisher Scientific.

Acquisition Description:

The NIH Clinical Center, Department of Transfusion Medicine (DTM), Infectious Diseases Section requires acquisition of a 1) Real-Time PCR System, 2) an Automated Nucleic Acid Extractor and 3) a microvolume spectrophotometer to support clinical research and the development, optimization, and validation of diagnostic assays for hepatitis viruses and other transfusion-transmitted pathogens.

The required system must support generation of high-quality quantification data from clinical specimens, including viral RNA/DNA and host-derived nucleic acids. The instrument must enable applications such as targeted genome amplification, work with a wider dynamic detection range, support the library prep for viral genome sequencing, and assay development workflows necessary for evaluating test performance and refining diagnostic methods prior to implementation in a clinical testing environment.

The system must meet the following functional and operational requirements:

  • High data accuracy and reproducibility to ensure reliable detection of viral variants and evaluation of assay performance;
  • Low- to moderate-throughput capability appropriate for assay development, pilot studies, and validation activities involving smaller sample sets;
  • Rapid turnaround times to support iterative testing and optimization of clinical assays;
  • Flexible run configurations that allow efficient processing of varying sample volumes without excess capacity;
  • Cost-efficient operation, including the ability to minimize per-run and per-sample costs for pathogen detection;
  • Integrated and streamlined workflows, including nucleic acid extraction, amplification, quantification and data analysis within a platform from the same vendor to reduce complexity and variability;
  • Ease of use and standardized operation, supporting reproducibility and implementation in a clinical laboratory environment;
  • Compatibility with established nucleic acid preparation and amplification methods and existing laboratory workflows.
  • The flexibility to be using the systems in a CLIA certified environment. 

The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000121) by 12:00 PM eastern standard time on 10/23/2026 to: valerie.gregorio@nih.gov.

All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

Files (2)

Lifecycle

  1. 1
    Version 1Special Notice

    Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center

    Notice b95b5fc579dd4e7fa6b27d283a9049ff on SAM.gov

  2. 2
    Version 2Special NoticeCurrent

    Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center

    Notice bf6b20798a274eb2936262d401e097a7 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

NOI-OLAO-CC-27-000121

Archive Date

Nov 7, 2026

Office Address

Bethesda, MD, 20892, US